In this post, “we” refers to Good Ventures and Open Philanthropy, who work as partners.
As we wrote last week, we’re substantially growing our overall giving in Global Health and Wellbeing, with the bar in that broad portfolio continuing to be set by the cost-effective, evidence-backed charities recommended by GiveWell. (As most of our readers know, Open Philanthropy started off as a project of GiveWell.)
Today we are excited to announce our largest-to-date support for GiveWell’s recommendations: $300 million for 2021, up from $100 million last year, with tentative plans to donate an additional $500 million per year in 2022 and 2023.
Like last year, some of this new $300 million has already been allocated to specific recommended charities, and some will be held in reserve until GiveWell has more information about which charities have the greatest remaining need for funds. Grants we’ve already made or are planning to make imminently include:
- $27 million to Malaria Consortium for insecticide-treated bednet distribution campaigns in two Nigerian states. We also contributed an additional $2 million for more extensive research on the use and durability of the nets and an attempt to collect better data on local malaria incidence and local mosquitoes’ susceptibility to the insecticide used in the bednets, to inform continual improvement in GiveWell’s cost-effectiveness estimates.
- $20 million to the International Rescue Committee (IRC) for malnutrition treatment in Chad, Niger, Somalia, Burkina Faso, and the Democratic Republic of the Congo and $7 million to The Alliance for International Medical Action (ALIMA) for malnutrition treatment in Chad. This is a new intervention for GiveWell, and they wrote about the scale of the need, evidence base, and open questions here.
- Up to $25 million (best guess $16 million) to IRD Global to support an electronic immunization registry and associated mobile phone-based conditional cash transfer program for immunizations in Sindh Province, Pakistan.
- $2.1 million to Pure Earth for work on reducing lead exposure in low- and middle-income countries.
This list reflects GiveWell’s impressive progress in identifying more cost-effective giving opportunities: none of these individual programs at these organizations had received funding from GiveWell prior to this year, and four of the five of the organizations and three of the four interventions are new to GiveWell overall.
As funds are distributed from this year’s $300 million allocation, they will be listed in our grants database.
The rest of this post gives more context on our reasoning for the decisions above, structured as a Q&A.
Why are you giving more than in previous years?
Based on the framework we explained last week, we’re giving more going forward because of:
- Dramatic growth in GiveWell’s identified cost-effective opportunities this year relative to last year, and a further increase in their expectation of giving opportunities they’ll find in the future.
- Significant growth in the assets we expect to eventually distribute, and in how much giving similar to ours that we expect others to do in the future.
- An increase in how we value saving lives relative to increasing income.
- More thorough work on how we expect these and other factors to interact, leading us to lower our “bar” (for how cost-effective grants need to be to spend now rather than save to donate later), by ~20% for GiveWell recommendations.
Much more technical detail on the interplay of these factors is available in our previous post.
Will GiveWell distribute all $300M this year?
No, we don’t expect them to. When combined with projected growth in donations from other donors, our increased allocation means that GiveWell expects to roll over roughly $100 million of funds raised this year into next year to grant in 2022. From GiveWell’s blog post:
We aim to find and fund around $1 billion of highly cost-effective giving opportunities annually by 2025. There’s an enormous amount of good that we can accomplish with our team and donors, and we’re excited to take on this ambitious challenge.
Our confidence in our ability to increase the amount of cost-effective funding we find—and our rapid growth—is driving some changes this year. While we could spend all of the funding we expect to raise in 2021 on opportunities now, we don’t think we should. We plan to roll over about $110 million (~20% of our forecasted funds raised) into 2022 because we expect the opportunities this funding would be spent on now are much less cost-effective than those we expect to find over the next few years.
There are tradeoffs to using funds later, but we think they strongly favor waiting for better opportunities. Our core mission is to help donors maximize their impact, not to get funding out the door as quickly as possible.
We expect GiveWell will likely be in a similar situation of rolling forward a meaningful amount of funding next year into 2023, but we nonetheless plan to increase our funding further.
Why are you committing so much in advance?
In addition to GiveWell’s reasoning above, we see several practical arguments for exceeding GiveWell’s already-identified opportunity set and publicly articulating our tentative expected giving to their recommendations in future years:
- This is a vote of confidence in GiveWell as a mature organization, and will give them more autonomy and predictability. Previously, we roughly planned around giving GiveWell recommendations 10% of our eventual giving, but also in principle wanted to fund all opportunities GiveWell would discover above our “bar”. That was administratively difficult because it made it hard for GiveWell to plan and could require that GiveWell and Open Philanthropy keep our different systems for assessing cost-effectiveness constantly in sync. With funding level plans, we can be a bit more loosely coupled, which is practically simpler, while still trying to optimize by keeping our bars roughly in sync over time.
- We have increasingly explicit goals for long-term spending levels in Global Health and Wellbeing. This has two implications: (a) it helps us manage our workload to directly delegate responsibility for some of the goals to GiveWell; and (b) setting explicit spending levels (rather than having annual spending respond to a fixed “bar”) better reflects the likelihood of correlated updates (e.g., in a world where GiveWell discovers tons of great opportunities, it seems more likely that our other work will too, and that the bar should rise, rather than us just filling everything GiveWell discovers at a fixed bar).
- We want GiveWell to be able to communicate clearly to their donors that marginal contributions are likely to effectively be disbursed in future years rather than immediately. We think these other donors should continue to support GiveWell if they seek to maximize the impact of their giving, but want them to have full context on our plans. (For what it’s worth, I still expect the bulk of my personal giving this year to go to the GiveWell Maximum Impact Fund, so I don’t think Open Philanthropy’s plans should be answer-changing for other individual donors.)
- If this level of funding means that GiveWell should lower their cost-effectiveness bar, we want them to be empowered to do so proactively. Lead times for developing and investigating future funding opportunities can be long, which is why GiveWell continues to hire more researchers.